
Martin Zapata Laguado: Honored to Speak on mRCC First-Line Therapy and dCN in the IO Era
Martin Zapata Laguado, Medical Oncologist and Internal Medicine Physician at the National Cancer Institute of Colombia, shared a post on X by Juan Pablo Rojas Manrique, Urologist-Oncologist at the University of Cartagena and at Nueva Granada Military University/National Cancer Institute (Colombia), adding:
“Honored to join Juan Pablo Rojas Manrique at the Colombian Society of Urology annual meeting to discuss first-line options in mRCC and the evolving role of dCN and residual disease management in the IO era. Improving the team.”
Quoting Juan Pablo Rojas Manrique’s post:
“Talking about deferred cytoreductive nephrectomy (dCN) at the SCU National Congress, after Martin Zapata Laguado’s great talk on systemic therapy.”
More posts featuring Martin Zapata Laguado.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023